デフォルト表紙
市場調査レポート
商品コード
1427780

診断用特殊抗体の世界市場レポート 2024年

Diagnostic Specialty Antibodies Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
診断用特殊抗体の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

診断用特殊抗体の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.9%の年間複合成長率(CAGR)で377億5,000万米ドルに成長すると予想されます。予測期間で予想される成長は、疾患バイオマーカーの急増、ポイントオブケア検査の迅速な導入、感染症の出現、バイオシミラーとジェネリック開発の進歩、人工知能と機械学習の統合によるものと考えられます。予測期間中に予想される主な動向には、アッセイ開発における技術進歩、ナノテクノロジーの導入、特異性と選択性の向上、ウェアラブルデバイスとの統合、進行中のアッセイの小型化が含まれます。

診断用特殊抗体市場の予想される成長は、HIV診断の患者プールの拡大によって促進されると予想されます。これは、HIV(ヒト免疫不全ウイルス)と診断される人の数が増加していることを指します。患者数の増加により、メーカーは、ウイルスに関連する特定のバイオマーカーの検出を容易にし、HIV感染の早期検出とモニタリングを支援する、HIV検査用の特殊な抗体ベースの診断製品を開発および供給する機会が生まれます。たとえば、2022年 7月の時点で、国連 HIV/エイズ共同計画(UNAIDS)は、世界のHIV感染者数が2020年の3,780万人から2021年の3,840万人へと1.6%増加したと報告しています。さらに、新たに約150万人が増加しています。 HIV感染症は2021年に報告されました。したがって、HIV診断を受ける患者数の増加が診断用特殊抗体市場の成長の原動力となっています。

がんの発生率の増加は、診断用特殊抗体市場の成長に寄与すると予想されます。異常細胞の制御されない分裂と増殖を特徴とするがんは、特定のがんマーカーを特定し、疾患の診断と監視を支援するために診断用特殊抗体の使用を促します。米国がん協会によると、2021年に米国で新たにがんと診断された患者数は190万人、がんによる死亡者数は60万8,570人と推定され、2020年に報告された新規がん患者数180万人、がんによる死亡者数60万6,520人から増加しています。がんの発生率は、診断用特殊抗体市場の重要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の診断用特殊抗体市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の診断用特殊抗体の市場規模実績と成長、2018年~2023年
  • 世界の診断用特殊抗体の市場規模と成長予測、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の診断用特殊抗体市場、抗体タイプ別セグメンテーション、実績および予測、2018年~2023年、2023年~2028年、2033年
  • モノクローナル抗体
  • ポリクローナル抗体
  • 組換えポリクローナル抗体
  • 世界の診断用特殊抗体市場、用途別セグメンテーション、実績および予測、2018年~2023年、2023年~2028年、2033年
  • 肝炎
  • 結核
  • デング熱
  • 腫瘍学
  • ヒト免疫不全ウイルス(HIV)
  • 感染症
  • その他の用途
  • 世界の診断用特殊抗体市場、エンドユーザー別セグメンテーション、実績および予測、2018年~2023年、2023年~2028年、2033年
  • 診断研究所
  • 病院

第7章 地域および国の分析

  • 世界の診断用特殊抗体市場、地域別、実績および予測、2018年~2023年、2023年~2028年、2033年
  • 世界の診断用特殊抗体市場、国別、実績および予測、2018年~2023年、2023年~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 診断用特殊抗体市場の競合情勢
  • 診断用特殊抗体市場の企業プロファイル
    • F. Hoffmann-La Roche AG
    • Sanofi SA
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation

第31章 その他の主要・革新的企業

  • Boehringer Ingelheim International GmbH
  • Merck KGaA
  • Becton Dickinson and Company
  • Regeneron Pharmaceuticals Inc
  • Agilent Technologies Inc.
  • Sartorius AG
  • Bio-Rad Laboratories Inc.
  • Quest Diagnostics Inc.
  • STEMCELL Technologies Inc.
  • Abcam PLC
  • Telix Pharmaceuticals Limited
  • Aytu BioScience Inc.
  • Enzo Life Sciences Inc.
  • Rockland Immunochemicals Inc.
  • Santa Cruz Biotechnology Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13624

Diagnostic specialty antibodies represent a category of antibodies meticulously designed and developed for diagnostic purposes. These antibodies find application in diverse diagnostic tests and assays aimed at detecting and identifying specific biomarkers, antigens, or pathogens present in patient samples.

The primary types of diagnostic specialty antibodies encompass monoclonal antibodies, polyclonal antibodies, and recombinant polyclonal antibodies. Monoclonal antibodies, derived from a single clone of immune cells, yield a uniform population of antibodies that target a specific antigen. These antibodies are employed across various applications, including diagnostics for hepatitis, tuberculosis, dengue, oncology, human immunodeficiency virus (HIV), infectious diseases, and more. Diagnostic laboratories and hospitals serve as key end users utilizing these antibodies.

The diagnostic specialty antibodies research report is one of a series of new reports from The Business Research Company that provides diagnostic specialty antibodies market statistics, including the diagnostic specialty antibodies industry's global market size, regional shares, competitors with a diagnostic specialty antibodies market share, detailed diagnostic specialty antibodies market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic specialty antibodies industry. This diagnostic specialty antibodies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diagnostic specialty antibodies market size has grown strongly in recent years. It will grow from $28.33 billion in 2023 to $29.97 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth observed in the historical period can be ascribed to progress in biotechnology, the advent of personalized medicine, enhanced understanding of diseases, advancements in immunoassay and diagnostic techniques, and the ascent of companion diagnostics.

The diagnostic specialty antibodies market size is expected to see strong growth in the next few years. It will grow to $37.75 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The anticipated growth in the forecast period can be ascribed to the proliferation of disease biomarkers, the swift adoption of point-of-care testing, the emergence of infectious diseases, advancements in biosimilar and generic development, and the integration of artificial intelligence and machine learning. Major trends expected in the forecast period encompass technological progress in assay development, the incorporation of nanotechnology, improved specificity and selectivity, integration with wearable devices, and the ongoing miniaturization of assays.

The anticipated growth of the diagnostic specialty antibodies market is expected to be fueled by the expanding patient pool for HIV diagnoses. This refers to the increasing number of individuals being diagnosed with HIV (Human Immunodeficiency Virus). The growing patient pool creates opportunities for manufacturers to develop and supply specialized antibody-based diagnostic products for HIV testing, facilitating the detection of specific biomarkers associated with the virus and aiding in the early detection and monitoring of HIV infection. For instance, as of July 2022, The Joint United Nations Programme on HIV/AIDS (UNAIDS) reported a 1.6% increase in the global population living with HIV, from 37.8 million in 2020 to 38.4 million in 2021. Additionally, around 1.5 million new HIV infections were reported in 2021. Therefore, the growing patient pool of HIV diagnoses is a driving force behind the growth of the diagnostic specialty antibodies market.

The increasing incidence of cancer is expected to contribute to the growth of the diagnostic specialty antibodies market. Cancer, characterized by the uncontrolled division and growth of abnormal cells, prompts the use of diagnostic specialty antibodies to identify specific cancer markers and assist in the diagnosis and monitoring of the disease. According to the American Cancer Society, there were an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States in 2021, marking an increase from the 1.8 million new cancer cases and 606,520 cancer deaths reported in 2020. Hence, the rising incidence of cancer is a significant driver for the diagnostic specialty antibodies market.

Major companies focusing on the introduction of novel products and solutions to consolidate their market position. A case in point is Creative Diagnostics, a US-based company in the biotechnology industry, which, in January 2023, launched 1,000 new targets. This includes carrier-free formulations and conjugated antibodies, expanding the company's monoclonal antibody capabilities and product offerings on a global scale. The newly introduced monoclonal antibodies are designed to be versatile and high-performing tools applicable in various scenarios, such as ELISA (enzyme-linked immunoassay) detection methods. Their single-epitope recognition ensures improved specificity. These antibodies, having undergone rigorous validation, are suitable for applications such as Western blotting (WB), flow cytometry (FC), immunohistochemistry (IHC), immunocytochemistry (ICC), immunofluorescence (IF), and immunoprecipitation (IP).

Major players in the diagnostic specialty antibodies market are concentrating on the development of innovative assays, specifically antibody assays, for diagnosing rare bleeding disorders and gaining a competitive advantage. An antibody assay is a laboratory technique used to identify and measure the presence and concentration of antibodies in a biological sample. For instance, in May 2023, Versiti, a US-based nonprofit organization, launched the Anti-von Willebrand Factor (VWF) Antibody Assay. This groundbreaking assay aids clinicians in identifying patients suspected of having acquired von Willebrand Disease (aVWD) by detecting both inhibitory and non-inhibitory antibodies binding to VWF, providing additional pathways for anti-VWF antibody detection.

In October 2022, Sebia, a France-based specialty diagnostic company, made an undisclosed acquisition of Zeus Scientific Inc. Through this strategic move, Sebia aims to enhance its capability to deliver high-value solutions to customers and patients while strengthening its foothold and operations in the United States. Zeus Scientific Inc. is a US-based in vitro diagnostic (IVD) company with expertise in antibody tests for autoimmune and infectious diseases.

Major companies operating in the diagnostic specialty antibodies market report are F. Hoffmann-La Roche AG, Sanofi SA, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Boehringer Ingelheim International GmbH, Merck KGaA, Becton Dickinson and Company, Regeneron Pharmaceuticals Inc., Agilent Technologies Inc., Sartorius AG, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., STEMCELL Technologies Inc., Abcam PLC, Telix Pharmaceuticals Limited, Aytu BioScience Inc., Enzo Life Sciences Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Creative Diagnostics, Novus Biologicals LLC, Confo Therapeutics SA, Precirix NV, Creative Biolabs Inc., Polymun Scientific Immunbiologische Forschung GmbH.

North America was the largest region in the diagnostic specialty antibodies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the diagnostic specialty antibodies market report during the forecast period. The regions covered in the diagnostic specialty antibodies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diagnostic specialty antibodies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diagnostic specialty antibodies market consists of sales of chimeric antibodies, single-chain antibodies, and bispecific antibodies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diagnostic Specialty Antibodies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diagnostic specialty antibodies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diagnostic specialty antibodies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diagnostic specialty antibodies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Antibody Type: Monoclonal Antibodies; Polyclonal Antibodies; Recombinant Polyclonal Antibodies
  • 2) By Application: Hepatitis; Tuberculosis; Dengue; Oncology; Human Immunodeficiency Virus (HIV); Infectious Disease; Other Applications
  • 3) By End User: Diagnostic Laboratories; Hospitals
  • Companies Mentioned: F. Hoffmann-La Roche AG; Sanofi SA; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diagnostic Specialty Antibodies Market Characteristics

3. Diagnostic Specialty Antibodies Market Trends And Strategies

4. Diagnostic Specialty Antibodies Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Diagnostic Specialty Antibodies Market Size and Growth

  • 5.1. Global Diagnostic Specialty Antibodies Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Diagnostic Specialty Antibodies Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Diagnostic Specialty Antibodies Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Diagnostic Specialty Antibodies Market Segmentation

  • 6.1. Global Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Polyclonal Antibodies
  • 6.2. Global Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hepatitis
  • Tuberculosis
  • Dengue
  • Oncology
  • Human Immunodeficiency Virus (HIV)
  • Infectious Disease
  • Other Applications
  • 6.3. Global Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostic Laboratories
  • Hospitals

7. Diagnostic Specialty Antibodies Market Regional And Country Analysis

  • 7.1. Global Diagnostic Specialty Antibodies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Diagnostic Specialty Antibodies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Diagnostic Specialty Antibodies Market

  • 8.1. Asia-Pacific Diagnostic Specialty Antibodies Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Diagnostic Specialty Antibodies Market

  • 9.1. China Diagnostic Specialty Antibodies Market Overview
  • 9.2. China Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Diagnostic Specialty Antibodies Market

  • 10.1. India Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Diagnostic Specialty Antibodies Market

  • 11.1. Japan Diagnostic Specialty Antibodies Market Overview
  • 11.2. Japan Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Diagnostic Specialty Antibodies Market

  • 12.1. Australia Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Diagnostic Specialty Antibodies Market

  • 13.1. Indonesia Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Diagnostic Specialty Antibodies Market

  • 14.1. South Korea Diagnostic Specialty Antibodies Market Overview
  • 14.2. South Korea Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Diagnostic Specialty Antibodies Market

  • 15.1. Western Europe Diagnostic Specialty Antibodies Market Overview
  • 15.2. Western Europe Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Diagnostic Specialty Antibodies Market

  • 16.1. UK Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Diagnostic Specialty Antibodies Market

  • 17.1. Germany Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Diagnostic Specialty Antibodies Market

  • 18.1. France Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Diagnostic Specialty Antibodies Market

  • 19.1. Italy Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Diagnostic Specialty Antibodies Market

  • 20.1. Spain Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Diagnostic Specialty Antibodies Market

  • 21.1. Eastern Europe Diagnostic Specialty Antibodies Market Overview
  • 21.2. Eastern Europe Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Diagnostic Specialty Antibodies Market

  • 22.1. Russia Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Diagnostic Specialty Antibodies Market

  • 23.1. North America Diagnostic Specialty Antibodies Market Overview
  • 23.2. North America Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Diagnostic Specialty Antibodies Market

  • 24.1. USA Diagnostic Specialty Antibodies Market Overview
  • 24.2. USA Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Diagnostic Specialty Antibodies Market

  • 25.1. Canada Diagnostic Specialty Antibodies Market Overview
  • 25.2. Canada Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Diagnostic Specialty Antibodies Market

  • 26.1. South America Diagnostic Specialty Antibodies Market Overview
  • 26.2. South America Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Diagnostic Specialty Antibodies Market

  • 27.1. Brazil Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Diagnostic Specialty Antibodies Market

  • 28.1. Middle East Diagnostic Specialty Antibodies Market Overview
  • 28.2. Middle East Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Diagnostic Specialty Antibodies Market

  • 29.1. Africa Diagnostic Specialty Antibodies Market Overview
  • 29.2. Africa Diagnostic Specialty Antibodies Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Diagnostic Specialty Antibodies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Diagnostic Specialty Antibodies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Diagnostic Specialty Antibodies Market Competitive Landscape And Company Profiles

  • 30.1. Diagnostic Specialty Antibodies Market Competitive Landscape
  • 30.2. Diagnostic Specialty Antibodies Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Sanofi SA
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Danaher Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Diagnostic Specialty Antibodies Market Other Major And Innovative Companies

  • 31.1. Boehringer Ingelheim International GmbH
  • 31.2. Merck KGaA
  • 31.3. Becton Dickinson and Company
  • 31.4. Regeneron Pharmaceuticals Inc
  • 31.5. Agilent Technologies Inc.
  • 31.6. Sartorius AG
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Quest Diagnostics Inc.
  • 31.9. STEMCELL Technologies Inc.
  • 31.10. Abcam PLC
  • 31.11. Telix Pharmaceuticals Limited
  • 31.12. Aytu BioScience Inc.
  • 31.13. Enzo Life Sciences Inc.
  • 31.14. Rockland Immunochemicals Inc.
  • 31.15. Santa Cruz Biotechnology Inc.

32. Global Diagnostic Specialty Antibodies Market Competitive Benchmarking

33. Global Diagnostic Specialty Antibodies Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Diagnostic Specialty Antibodies Market

35. Diagnostic Specialty Antibodies Market Future Outlook and Potential Analysis

  • 35.1 Diagnostic Specialty Antibodies Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Diagnostic Specialty Antibodies Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Diagnostic Specialty Antibodies Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer